Welcome to LookChem.com Sign In|Join Free

CAS

  • or
3-(OXAZOL-2-YL)BENZOIC ACID, also known as OXBA, is a chemical compound with the molecular formula C10H7NO3. It is a white to off-white solid that is sparingly soluble in water. OXBA is a carboxylic acid compound with a substituted benzene ring and an oxazole group. Its structure and functional groups make it a versatile intermediate for creating various drug candidates and pharmaceutical compounds.
Used in Pharmaceutical Research:
3-(OXAZOL-2-YL)BENZOIC ACID is used as a building block in organic synthesis for the development of new drug candidates. Its unique structure and functional groups allow for the creation of a wide range of pharmaceutical compounds with potential therapeutic applications.
Used in Materials Science:
3-(OXAZOL-2-YL)BENZOIC ACID is used as a component in the production of polymers and liquid crystals. Its chemical properties and versatility make it a valuable asset in the development of new materials with specific properties and applications.

473538-18-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 473538-18-0 Structure
  • Basic information

    1. Product Name: 3-(OXAZOL-2-YL)BENZOIC ACID
    2. Synonyms: 3-(OXAZOL-2-YL)BENZOIC ACID
    3. CAS NO:473538-18-0
    4. Molecular Formula: C10H7NO3
    5. Molecular Weight: 189.17
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 473538-18-0.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 3-(OXAZOL-2-YL)BENZOIC ACID(CAS DataBase Reference)
    10. NIST Chemistry Reference: 3-(OXAZOL-2-YL)BENZOIC ACID(473538-18-0)
    11. EPA Substance Registry System: 3-(OXAZOL-2-YL)BENZOIC ACID(473538-18-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 473538-18-0(Hazardous Substances Data)

473538-18-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 473538-18-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,7,3,5,3 and 8 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 473538-18:
(8*4)+(7*7)+(6*3)+(5*5)+(4*3)+(3*8)+(2*1)+(1*8)=170
170 % 10 = 0
So 473538-18-0 is a valid CAS Registry Number.

473538-18-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-(1,3-Oxazol-2-yl)benzoic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:473538-18-0 SDS

473538-18-0Downstream Products

473538-18-0Relevant articles and documents

DOPAMINE D3 RECEPTOR ANTAGONISTS COMPOUNDS

-

Page/Page column 152, (2016/05/19)

The disclosure is directed to novel dopamine D3 receptor antagonists, processes for their preparation, intermediates used in these processes, pharmaceutical compositions containing them and their use in therapy, including treating drug dependency and psychosis.

Dihydro-benzo [b] [1,4] diazepin-2-one derivatives

-

, (2008/06/13)

This invention is a dihydro-benzo [b] [1,4] diazepin-2-one derivative of the formula wherein R1, R2, R3 and Y are as defined in the specification. The invention includes pharmaceutical compositions containing these compounds, a process for their preparation and a method of treatment or prevention of acute and/or chronic neurological disorders by administering an effective amount of the compound of formula I or a pharmaceuticall acceptable salt thereof.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 473538-18-0